Auxilium Pharmaceuticals has no intention of accepting a multibillion-dollar bid from Endo, the company said, preferring to stay the course and pull off an en-vogue tax inversion as it looks to cut costs.

…read more

Source: Auxilium shakes off Endo’s $2.2B offer and affirms its eye on QLT